Based on the enhanced expression patterns of pathological insoluble TDP-43 observed in mouse brains with acute ischemic stroke, we were interested in further exploring the therapeutic efficacy of rapamycin for eliminating TDP-43-mediated pathology in ischemic stroke. The gene discussed is TARDBP; the disease is ischemic stroke.